Following a public consultation in 2022, the Medicines and Healthcare products Regulatory Agency (the "MHRA") and Health Research Authority ...
The Medicines and Healthcare products Regulatory Agency (MHRA) has published draft regulations reforming pre-market requirement for medical ...
The aligned pathway for UK drugs regulator MHRA and reimbursement authority NICE – aimed at slashing the time it takes for new medicines to reach patients – will start to deliver guidance in June, ...
The MHRA has approved donidalorsen for long-term prevention of hereditary angioedema, a rare disorder causing potentially life-threatening swelling.
Submission of a UK Marketing Authorization Application for AMT-130 is expected in the third quarter of 2026 ~~ Type B Meeting with U.S. FDA ...
The Society for Editing conference, editors cheered — and groaned — as the AP Stylebook announced one of its most anticipated changes ...
Dublin, April 15, 2026 (GLOBE NEWSWIRE)-- The "Data Integrity and Document Management (June 22, 2026)" training has been added to ResearchAndMarkets.com's offering. Document management and data ...
Spinal muscular atrophy (SMA) is a rare, genetic condition that, across all types, affects ~1,600 people in the UK.1 It can cause muscle weakness which gets worse over time, causing movement, ...
New authorisation offers additional option for patients with lvef ≥40% Bayer has received MHRA approval for Kerendia (finerenone) for adults in the UK with symptomatic chronic heart failure and a left ...
The Medicines and Healthcare products Regulatory Agency (MHRA) has granted approval for Kerendia ® (finerenone), a non-steroidal, selective mineralocorticoid receptor antagonist (nsMRA), for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results